A 360-degree look at health care politics, policy, providers, and personalization that offers leaders important perspectives to successfully shape US health care after COVID-19 Over the past decade, the health economy has experienced the most dramatic change since the passage of Medicare and Medicaid in 1965. The Affordable Care Act's expansion of Medicaid, demographic-driven Medicare growth, and the digitization of health records have rapidly changed the traditional dynamics of the field-and the pandemic has accelerated this process. Experienced and aspiring health sector leaders must navigate an increasingly complex health care landscape in order to conceive, create, and implement solutions to improve our health care system now and in the future. The New Health Economy provides health professionals with a 360-degree look at the field by exploring four pillars of the health economy: politics, policy, providers, and personalization. Topics covered include the federal government's role as the largest payer and regulator of health care, health care finance and the shift from the fee-for-service model toward value-based care, the increasing consolidation of provider networks, and data-driven personalizations inside and outside of the field. Drawing from interviews with top leaders in the field-including a former CDC director, a former FDA commissioner, and the current CEOs of Pfizer and Johnson & Johnson-this essential guide compares each sector before and during the COVID-19 crisis. These comparisons shed light on how the pandemic has accelerated recent trends in health care and provide leaders with an outline for a strategic path forward. The New Health Economy brings together the best thinking from across the health care sector, providing insight into COVID-19's impact on the health economy and setting the ground rules required to shape a new health care system as we emerge from the pandemic. This valuable resource will benefit CEOs and other leaders in the health economy, from hospitals to provider networks and beyond.

The research featured in this volume is devoted to understanding the competitive and collaborative challenges that firms face as they manage interactions with different actors in dynamic environments, in what are coming to be referred to as business or innovation 'ecosystems'. Rapid technological change, globalization, and recent financial turbulence have brought us to a point where managers are painfully aware that 'no man [or firm] is an island.' Success in business, in both the profit and non-profit sectors, increasingly relies upon collaboration with upstream suppliers, alliance partners, and downstream complementors. This volume presents new findings of how innovation and value are created in collaborative networks, specifically 'ecosystem analysis' and the unique roles of individual actors within this system

How can great companies do everything right - identify real customer needs, deliver excellent innovations, beat their competitors to market - and still fail? The sad truth is that many companies fail because they focus too intensely on their own innovations, and then neglect the innovation ecosystems on which their success depends. In our increasingly interdependent world, winning requires more than just delivering on your own promises. It means ensuring that a host of partners -some visible, some hidden- deliver on their promises, too. In The Wide Lens, innovation expert Ron Adner draws on over a decade of research and field testing to take you on far ranging journeys from Kenya to California, from transport to telecommunications, to reveal the hidden structure of success in a world of interdependence. A riveting study that offers a new perspective on triumphs like Amazon's e-book strategy and Apple's path to market dominance; monumental failures like Michelin with run-flat tires and Pfizer with inhalable insulin; and still unresolved issues like electric cars and electronic health records, The Wide Lens offers a powerful new set of frameworks and tools that will multiply your odds of innovation success. The Wide Lens will change the way you see, the way you think - and the way you win.

A 360-degree look at health care politics, policy, providers, and personalization that offers leaders important perspectives to successfully shape US health care after COVID-19 Over the past decade, the health economy has experienced the most dramatic change since the passage of Medicare and Medicaid in 1965. The Affordable Care Act's expansion of Medicaid, demographic-driven Medicare growth, and the digitization of health records have rapidly changed the traditional dynamics of the field-and the pandemic has accelerated this process. Experienced and aspiring health sector leaders must navigate an increasingly complex health care landscape in order to conceive, create, and implement solutions to improve our health care system now and in the future. The New Health Economy provides health professionals with a 360-degree look at the field by exploring four pillars of the health economy: politics, policy, providers, and personalization. Topics covered include the federal government's role as the largest payer and regulator of health care, health care finance and the shift from the fee-for-service model toward value-based care, the increasing consolidation of provider networks, and data-driven personalizations inside and outside of the field. Drawing from interviews with top leaders in the field-including a former CDC director, a former FDA commissioner, and the current CEOs of Pfizer and Johnson & Johnson-this essential guide compares each sector before and during the COVID-19 crisis. These comparisons shed light on how the pandemic has accelerated recent trends in health care and provide leaders with an outline for a strategic path forward. The New Health Economy brings together the best thinking from across the health care sector, providing insight into COVID-19's impact on the health economy and setting the ground rules required to shape a new health care system as we emerge from the pandemic. This valuable resource will benefit CEOs and other leaders in the health economy, from hospitals to provider networks and beyond.